A Study of LY3537031 in Overweight, Obese, and Healthy Participants (clinicaltrials.gov) - Oct 1, 2026 - P1 | N=302 | Active, not recruiting | Sponsor: Eli Lilly and Company | Trial completion date: Jul 2026 ➔ Nov 2026 | Trial primary completion date: Jul 2026 ➔ Nov 2026
Trial completion date • Trial primary completion date • Genetic Disorders • Obesity
|